Purchase Order 75N95021P00291
- Not listed
- <p>The National Institutes of Health National Institute on Aging awarded a $600,000 Purchase Order to Psomagen Inc. of Potomac, Maryland to provide Whole Genome Sequencing Services for 1,000 samples. The contract has a period of performance from September 22, 2022 through September 21, 2023 and utilizes a Firm Fixed Price pricing structure. No subcontractors were identified.</p>
- This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...
- This is a $64,800 firm-fixed price purchase order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Psomagen Inc. for RNA sequencing services to support neurodegenerative disease research. The contract has a period of performance from August 1, 2024 to December 31, 2024. Psomagen will provide total RNA sequencing, including library preparation, sequencing, and data delivery, for 324 human samples. This is a non-competitive award, as Psomagen...
- This firm fixed-price purchase order awards Psomagen Inc. $422,000 to provide RNA sequencing services to the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), from June 2021 through June 2023. The contract supports NIA research on Alzheimer's disease and related dementias by requiring the contractor to construct sequencing libraries from 20 human samples, perform sequencing on an Illumina NovaSeq 6000 platform, and deliver various data files. No set-aside...
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Aging (HHS-NIH-NIA) awarded a $600,000 purchase order contract to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide Epigenome Sequencing Services. The contract has a period of performance starting on June 1, 2023 through May 31, 2024 and utilizes a firm fixed price pricing structure. The place of performance will be Potomac, Maryland. No subcontractors were identified.</p>
- <p>The National Institutes of Health National Institute on Aging awarded a $288,900.00 purchase order to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide single cell multiome sequencing services from July 3, 2023 through July 2, 2024. The firm fixed price contract will support Psomagen in conducting single cell multiome sequencing at its facility located in Potomac, Maryland to assist the National Institutes of Health National Institute on Aging in advancing biomedical research.</p>
- This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...
- This federal contract, awarded by the National Institute on Aging (a civilian agency of the U.S. government), is for the purchase of whole genome sequencing services from the prime contractor, Psomagen Inc. The contract has a total ceiling value of $7,499,725.00 and is set aside for small businesses. Psomagen Inc. is a subsidiary of Macrogen, Inc. that specializes in providing a range of genomic sequencing, bioinformatics, and related services to federal agencies. Through this contract, Psomagen...
- This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for epigenome sequencing services using the Illumina NovaSeq platform. The $83,750 firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health. The award was not set aside for small businesses. Psomagen Inc. is an experienced provider of genomic services to federal agencies, having supported research initiatives at the NIH, USDA, and...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract, valued at $4,942.00, is for DNA sequencing services. It is not a set-aside contract. The contract supports NIAID's research efforts, potentially including work on neurodegenerative diseases, cancer, and infectious diseases. Psomagen has previously received...
This firm-fixed price purchase order for $600,000 was awarded by the National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, to Psomagen, Inc. for whole genome sequencing services. Under the terms of the contract, Psomagen will sequence 1,000 human samples to 30x coverage using Illumina sequencing technologies and deliver raw sequencing data files within 4-6 weeks. The work will be performed in Potomac, Maryland over a one year period ending June 2022. The solicitation sought quotes to support neurodegenerative disease research by generating whole genome sequences for 1,000 samples to the specified coverage level within the allotted timeframe. No set aside provisions applied. Parent company Macrogen, Inc. is listed as the prime contractor for this purchase order awarded without full and open competition.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Neurodegenerative Disease Research | HHS-NIH-NIDA(AG)-SBSS-75N95021Q00153 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Pre-Solicitation 1/2 | 4/20/21, 11:07 AM | |
Neurodegenerative Disease Research | 75N95021Q00153 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 2/2 | 6/7/21, 7:36 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 6/7/22 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 10/27/21 | |
| Not listed | Not listed | $600.0k | 6/17/21 |